Casdin Capital, LLC
Top Portfolio Positions
34 positions ·
$1,443,707,456 total
· as of Dec 31, 2025
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| WGS |
GeneDx Holdings Corp.
|
3,007,164 | $391,111,749 | 27.09% |
| RVMD |
Revolution Medicines, Inc.
|
2,577,333 | $205,284,573 | 14.22% |
| BLFS |
Biolife Solutions Inc
Healthcare
|
5,957,165 | $144,044,249 | 9.98% |
| LAB |
Standard Biotools Inc.
|
88,783,856 | $113,643,335 | 7.87% |
| RLAY |
Relay Therapeutics, Inc.
|
13,003,574 | $110,010,236 | 7.62% |
| ILMN |
Illumina, Inc.
|
600,000 | $78,696,000 | 5.45% |
| BEAM |
Beam Therapeutics Inc.
|
1,600,000 | $44,352,000 | 3.07% |
| GH |
Guardant Health, Inc.
|
380,000 | $38,813,200 | 2.69% |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
758,857 | $31,439,445 | 2.18% |
| DNLI |
Denali Therapeutics Inc.
|
1,840,000 | $30,378,400 | 2.10% |
Portfolio Trend
Holdings in TEM
Export CSVShares Held
Position Value (USD)
2 of 2 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $17,368,199 | 294,127 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $23,738,990 | 294,127 | Shares | Sole | 2025-11-14 | |
| No quarters match your search. | ||||||